Summit Therapeutics (SMMT) Ownership - Who owns Summit Therapeutics?
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SMMT showed earnings on August 11, 2025. You can read more about the earnings report here.